THERAKOS INC.;MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED;MALLINCKRODT CRITICAL CARE FINANCE INC.;MALLINCKRODT IP;MALLINCKRODT PHARMA IP TRADING D.A.C.;INO THERAPEUTICS LLC
发明人:
申请号：
IL23909915
公开号：
IL239099A
申请日:
2015.05.31
申请国别(地区):
IL
年份:
2019
代理人:
摘要：
The present invention generally relates to, amongst other things, systems, devices, materials, and methods that can improve the accuracy and/or precision of nitric oxide therapy by, for example, reducing the dilution of inhaled nitric oxide (NO). As described herein, NO dilution can occur because of various factors. To reduce the dilution of an intended NO dose, various exemplary nasal cannulas, pneumatic configurations, methods of manufacturing, and methods of use, etc. are disclosed.
